NCT02505737

Brief Summary

There is a critical need for treatments that address depression and barriers to mental health care in Parkinson's disease (PD). This randomized-controlled trial will evaluate a 10-session telephone-guided cognitive behavioral self-help program (TH-CBT) for depression in PD (dPD). 72 people with dPD (and their caregivers) will receive either TH-CBT plus enhanced usual care (INTERVENTION GROUP) or enhanced usual care only (CONTROL GROUP). Groups will be compared at baseline, midpoint, endpoint, and 1 and 6 months post-treatment. Participants assigned to the control group with have the opportunity to receive the experimental intervention (TH-CBT) after the data collection period (e.g., after the 6-month follow-up evaluation). Given the public health impact of improved depression treatment in PD, the knowledge to be gained may be significant and the project could directly impact clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Jul 2015

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

July 21, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

February 19, 2019

Status Verified

February 1, 2019

Enrollment Period

3 years

First QC Date

July 21, 2015

Last Update Submit

February 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depression on the Hamilton Depression Rating Scale

    clinician-administered scale- depression

    9 months

Secondary Outcomes (3)

  • Treatment Response on the Clinical Global Impression- Improvement Scale

    9- months

  • Anxiety on the Hamilton Anxiety Rating Scale

    9-months

  • Quality of life on the SF-36

    9-months

Study Arms (2)

TH-CBT

EXPERIMENTAL

The treatment works by teaching people with PD (PWP) the coping skills needed to manage their emotional reactions to the numerous challenges posed by the disease. Specifically, the treatment targets maladaptive thought patterns (e.g., I have no control; I am helpless) and behaviors (e.g., social isolation, lack of exercise, poor sleep habits, excessive worry), and critically, provides caregivers with the tools needed to encourage the PWPs' practice of their newly acquired coping skills. Treatment is administered over the phone and no travel is required.

Behavioral: TH-CBT

Enhanced Usual Care

OTHER

All participants will continue to receive their routine medical treatment under the supervision of their personal doctors (e.g., neurologists, psychiatrists, primary care physicians, therapists) while participating in the study. This routine treatment (e.g., usual care) will be further enhanced with the provision of written educational materials for effective coping with PD, the close clinical monitoring of depressive symptoms by study staff, and the provision of counseling resources in the local community.

Other: Enhanced Usual Care

Interventions

TH-CBTBEHAVIORAL

Telephone-Based Cognitive Behavioral Therapy (TH-CBT). A 10-session treatment protocol that incorporates behavioral activation, thought monitoring and restructuring, relaxation training, worry control, sleep hygiene, and caregiver psychoeducation and support

TH-CBT

Community-based treatment as usual and supplemental reading material

Enhanced Usual Care

Eligibility Criteria

Age35 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of Parkinson's disease.
  • Clinically significant depressive symptoms (e.g., symptoms are pervasive, distressing, and make life harder). The presence of a formal depressive disorder will be determined by study staff based on standardized criteria (e.g., SCID).
  • years old
  • Stable medication regimen ≥ 6 weeks
  • No change in mental health treatment in the past 2 months
  • Family member or friend willing to participate
  • Access to a telephone
  • Live in the United States of America (USA)

You may not qualify if:

  • Suicidal plans or intent
  • Probable Dementia or Significant Cognitive Impairment
  • Significant motor fluctuations (i.e., ≥ 50% of the day)
  • Unstable medical conditions
  • Bipolar, Psychotic Spectrum, or Substance Abuse Disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers University-Robert Wood Johnson Medical School

Piscataway, New Jersey, 08854, United States

Location

Related Publications (1)

  • Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial. Neurology. 2020 Apr 21;94(16):e1764-e1773. doi: 10.1212/WNL.0000000000009292. Epub 2020 Apr 1.

MeSH Terms

Conditions

DepressionParkinson Disease

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Roseanne D Dobkin, PhD

    Rutgers Robert Wood Johnson Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

July 21, 2015

First Posted

July 22, 2015

Study Start

July 1, 2015

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

February 19, 2019

Record last verified: 2019-02

Locations